Trial
NCT02403895
AZD2014 and Weekly Paclitaxel in Squamous NSCLC
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
—
Condition
Squamous Non Small Cell Lung Cancer
Intervention
Open-label AZD2014
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-03